Nursing Care Plan PackageC
Nursing Care Plan PackageC
Nursing Care Plan PackageC
Preceptor and SN; Initial observation: 08:30a.m. NPO: The patient is alert and able to state her name
and date of birth. She is sitting in a semi- fowlers position with TV on. I introduced myself. as a Sn and stated I
would be working the her nurse: Noted bilaterally 22g peripheral IVs taped, secure and intact, no s/s of redness
or infiltration Left hand heplocked, Right has 0.9ns infusing @ 125cc via pump. Foley to gravity with 300 cc of
light urine. Q4 hr Finger sticks, 264; administered : 4 units of regular insulin per s/s, given sq in right upper
arm. Pantoprazole 40mg IVP. Abdomen large taunt. Daily Vitals signs completed. Noted abdomen large taunt
patient denies pain at this time. Observed patient guarding her stomach with facial expression of pain. I asked
the patient if she would like to have some pain medication and from 1 to 10 what was her pain level? She stated
it was at a 7. Administered Morphine 5 mg Ivp for pain. (alcohol wipe – ns flush before and after med
administered______________________________________________________________________________________MMinor:sn
SN: 09:00 Returned to observe patient; when asked about the pain she stated it was “much better and it
didn’t hurt anymore.” Ice chip at her bedside. Bed in low position- side- rails up x2 call-bell in reach
_____________________________________________________________________________________________MMinor:sn
Preceptor and SN; 09:15a.m. Assessment of patient reveals she is no longer in pain, talking on her phone
and rubbing her abdomen, I, with permission check her lower extremities, bilaterally warn to touch with full
range of motion, no pedal edema, peripheral pulses normal. No joint swelling. Good capillary refill. No petechiae
or ecchymosis noted._______________________
________________________________________________________________________________________________MMinorsn
SN: 11.15a.m Patent is in bed asleep – snoring; top side-rails up, remains in semi-fowlers position,
respirations easy, non-labored, color within normal limits, resting on her left side. Call-bell remains in
reach.________________________________
_____________________________________________________________________________________________MMinorsn
SN: 12:00 Patients remains pain free as expressed. CBG 150, no sliding scale coverage, Respiration remain
easy non-labored, color within normal limits, as observed q2 hour checks, in no apparent distress at this
time._________________
_____________________________________________________________________________________________MMinorsn
Preceptor and SN; 1250; Report off to preceptor, condition of patient is stable she is pain free at this time.
____________________________________________________________________________________________Mminorsn
(4)
Pathophysiology
2. Clients at Risk: A block in the ducts between the pancreas and the liver. This includes gallstones that force
pancreatic fluids to back up, causing inflammation and permanent damage. Tumors, Chemicals in the digestive
system, Inflammation of nearby organs antibiotics, such as sulfa drugs and tetracycline, high exposure to
estrogen and some diuretics, binge drinking or regularly drinking large amounts of alcohol, abdominal surgery
complications from a screening procedure called endoscopic retrograde cholangiopancreatography (ERCP),
Infections (such as mumps or viral hepatitis), high levels of calcium or triglycerides in the blood. People at risk
of gallstones are also at risk for acute pancreatitis. This includes pregnant women, women who have had many
pregnancies and people who are overweight.
3. Effects on Client (signs & symptoms): Symptoms of the acute form include pain upper part the stomach
area. The abdomen is rigid and tender.
SIGNS: nausea, vomiting, bloating, belching, hiccups and/or collapse. The patient may have steady which radiate to
the back, side or lower stomach area. The patient may also have a fever, shortness of breath or kidney problems if
the symptoms are severe. The patient may also be constipated, have a slow pulse and show signs of and show signs
of jaundice.
3. How diagnosed (X-rays, lab test, etc.) Diagnostic Test for Pancreatitis are: computed tomography (CT),
ultrasound of the gallbladder. Abdominal x-rays, 3 series, arterial blood gases, BMP, CBC, Urine Drug screen,
lipase, Hemoglobin A1c
How Treated: Treatment options offered for Pancreatic Diseases include: Noninvasive
photo-dynamic therapy, a treatment for bilary strictures, Drug therapy for all pancreatic disorders, Noninvasive
photo-dynamic therapy, a treatment for bilary strictures, Drug therapy for all pancreatic disorders, Endoscopic
pancreatic therapy to help alleviate pain and improve pancreatic duct drainage in patients with chronic pancreatitis,
Enzyme therapy, which can aid nutritional absorption of food and curb weight loss.
Medications: Cotazym, Pancreatin, Pancrelipase, lipram-Cr20, Pancrease MT– Action- Inhibit pancreatic secretions
4. Expected Outcome (chronic, corrected with treatment, death, etc.): The expected outcomes the patient will be
pain free (opioid analgesia The patient will understand the importance of nutritional planning.
5. Possible Complications: Acute pain relief is the first priority for patients with chronic pancreatitis Diabetes
Mellitus, chronic steatorrhea ,high risk for biliary obstruction a serious and painful complication Disrupted skin
integrity, after each stool use a soothing emollient such as Sween Cream, zinc oxide cream.
6. Specific Nursing Actions: The focus of caring for the patient with chronic pancreatitis is pain management,
assist in maintaining a nutritional intake and prevent reoccurrence. psychosocial adaptation to a chronic illness
and alcoholic abstinence. (www.aa.org) Teach the patient to take the pancreatic enzyme before or at the
beginning of the meal. Disrupted skin integrity, after each stool use a soothing emollient such as Sween
Cream, zinc oxide cream. Surgical management is not a primary intervention for the treatment of chronic
pancreatitis.
7. References (must give page number or exact web address)
1. Mosby’s Nursing Drug Reference by Darlene Como, page 767,768
2. Medical-Surgical Nursing 6th edition by Ignatavicius and Workman page 1378, 1386
3. http://www.cedars-sinai.edu/2204.html
8. Individualize to your client care: This patient will have to make new life changes. She is scared because this is
her first hospital admittance. She must focus on new medical problems. I am hoping social services will help
direct her, she’ll need diabetic consultation, glucometer, supplies, and on-going teaching for her new onset
diseases. A referral to Al-Anon (www.al-anon.org) self help groups, are available to her drug problem.
Education is the key to change for developing a different live style.
STUDENT: M Minor
Clinical Worksheet MIDLAND COLLEGE
PRIMARY: Cameron
Room:405 Name: m.n MR#00000
DX: DR. Bighook
ALLERGY:NKA DIET: NPO
8:00VS:T99.0 P86 R20 BP138/86 O2 Sat 99% Pain Assessment 7 Tolerable level:
3
12:00VS:T98.8 P R BP121/86 O2 Sat 97% Pain Assessment 0
Tolerable level: 3
ASSESSMENT:Neuro, Skin, Musculo/Skeletel, Resp, Cardio, GI, Gu, Surgical wounds/Dressings, Mental
IV:Sol. D5ns Amount:1000cc rate 250cc
Desired Effect (Use): Severe pain, Depresses pain impulse transmission at the
spinal cord level by interactiong with opioid
• Pain: location, type, character; give dose before pain becomes severe:
• Bowel status; constipation common
• I&O ratio; Check for decreasing output
• B/P, pulse, respirations, (character, depth, rate)
• CNS changes: dizziness, drowsiness’, hallucinations, euphoria, LOC,
pupil reaction.
Amount of solution needed for dilution and rate of administration: After diluting
with 5 ml or more sterile H2O or NS; give 15 mg or less over 4-5 minutes
Reference Book and Page Numbers Mosby’s Nursing Drug Reference 2007 Pge
694-5
Client dose, Route & /Reason….. 5mg, IVP, Pain Management PRN Q2 hours
.
Medication Sheet
Desired Effect (Use): Suppresse gastric secretions, blocks final step of acid
production
Reference Book and Page Numbers Mosby’s Nursing Drug Reference 2007
page770 -771
Drug Name (brand & Generic): sodium Chloride 0.9% (Normal Saline)
Amount of solution needed for dilution and rate of administration: 1000cc per bag
Client’s Dose, Route & Reason: 0.9 sodium chloride, 250cc hour, IV, continously
Isotonic saline fluids such as 0.9% sodium chloride solution can temporarily expand
the extracellular compartment during times of circulatory insufficiency, replenish
sodium and chloride losses, treat diabetic ketoacidosis, and replenish fluids in the
early treatment of burns and adrenal insufficiency. Because their osmolality is
similar to that of blood, they're also the standard flush solutions used with blood
transfusions. 0.9% Sodium Chloride Injection, USP contains 9 g/L Sodium
Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154
mEq/L sodium and 154 mEq/L chloride.
The flexible container is made with non-latex plastic materials specially designed for
a wide range of parenteral drugs including those requiring delivery in containers
made of polyolefins or polypropylene. For example, the AVIVA container system is
compatible with and appropriate for use in the admixture and administration of
paclitaxel. In addition, the AVIVA container system is compatible with and
appropriate for use in the admixture and administration of all drugs deemed
compatible with existing polyvinyl chloride container systems. The solution contact
materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety of the
container system. The flexible container is a closed system, and air is prefilled in
the container to facilitate drainage. The container does not require entry of external
air during administration.
The container has two ports: one is the administration outlet port for attachment of
an intravenous administration set and the other port has a medication site for
addition of supplemental The primary function of the overwrap is to protect the
container from the physical environment.
dxWrapDistLeft95250dxWrapDistRight95250wzTooltip"IV Solution by
Medline"posrelv3fLayoutInCell1fAllowOverlap0fIsButton1fLayoutInCell1
CARE PLAN FORM #______
Name___________________________________________________Date____________________
Document Satisfactory or Unsatisfactory Comments:
Name Date
Faculty Builds performance on previously learned skills Performanc
e
1. Theoretical knowledge: Bath, Bed, AM Care, Treatments (IS), Theory:
Mobility and Safety.
2. Critical Thinking: Disease Process, Education, Medication Thinking:
Rationale and Adm.
3. Communication: Report, Therapeutic and Interdisciplinary Com:
Communication.
4. Caring: Nurse Advocate, Empathy and Rapport. Caring:
5. Management: Completion of Skills and Documentation. Manage:
6. Professional Behaviors: Confidentiality, Punctual, and Behaviors:
Respectful.
Student Comments: Faculty Comments: Faculty
Comments:
_____Medication Administration:
_____Treatments:
_____Med
Adm:
_____Professionalism:
_____Treatme
____Accepts responsibility for nts:
nursing care:
____Accepts
resp:
____Seeks
learning
opportunities
Strategies for improving: Recommendations: Recommend
ations:
_____Clinical Incident Report
_____Mandat
ory Skills
Lab for 4
hour
due
by__________
Faculty Faculty
Signature_______________________ Date
Date___
My signature indicates that I have read the above statements and am aware of my
clinical performance.
Signature Date